Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × rezivertinib × Clear all

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Capecitabine 27 Paclitaxel 23 Oxaliplatin 23 Cisplatin 20 Gemcitabine 18 Fluorouracil 18 Drug Therapy 18 Docetaxel 18 Carboplatin 17 Leucovorin 15 pembrolizumab 13 Irinotecan 13 tislelizumab 12 Magnetic Resonance Spectroscopy 11 Radiotherapy 10 Specimen Handling 9 Pemetrexed 9 toripalimab 8 Injections 8 Standard of Care 7 Radiotherapy, Intensity-Modulated 7 Letrozole 7 Bevacizumab 7 Azacitidine 7 venetoclax 6 sintilimab 6 Trastuzumab 6 Surgical Procedures, Operative 6 Radiation 6 Cyclophosphamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06955325 2025-05-06

UPLIFT

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡